Orphan Drugs for Cancer Pipeline Industry Analysis

1
Orphan Drugs for Cancer Pipeline Analysis
Published Date October 2013 No. of Pages 855
Price Single User US 1440 Price Corporate
User US 1920
2
New Market Research Report on Orphan Drugs for
Cancer Pipeline Analysis added to
ReportsnReports.com
Order report Orphan Drugs for Cancer Pipeline
Analysis by calling ReportsnReports.com at 1
888 391 5441 OR send an email on
sales_at_reportsandreports.com with Orphan Drugs
for Cancer Pipeline Analysis in subject line and
your contact details. A huge
market opportunity is offered by small patient
population which suffers from rare or orphan
diseases. Among the category of new orphan drugs,
Oncology account for the largest disease group in
recent years. It has been observed that majority
of the orphan drugs in the clinical stages are
for rare cancer disease drugs, and are in the
late stages of the pipeline. Some of the drugs
are being developed for treating rare cancer
diseases like solid tumor of the pancreas and
thyroid, blood cancer, melanoma, and
others. Orphan Drugs for Cancer Pipeline
Analysis by PNS Pharma gives comprehensive
insight on the various orphan designated drugs
being developed for the treatment of multiple
cancers. Research report covers all the ongoing
vaccines being developed in various development
phases. This report enables pharmaceutical
companies, collaborators and other associated
stake holders to identify and analyze the
available investment opportunity in the market
for orphan designated cancer drugs based upon
development process. Inquiry Before Buying on
this Report _at_ http//www.reportsnreports.com/conta
cts/inquirybeforebuy.aspx?name269589 .
3
Orphan Drugs for Cancer Pipeline Analysis

• Following parameters for each orphan designated
  drug profile in development phase are covered in
  Orphan Drugs for Cancer Pipeline Analysis
  research report
• Drug Profile Overview
• Alternate Names for Drug
• Active Indication
• Phase of Development
• Detailed Therapeutic Trials
• Mechanism of Action
• Brand Name
• Patent Information
• Orphan Designation by Indication, Country
  Organisation
• Country for Clinical Trial
• Owner / Originator/ Licensee/Collaborator
• Administrative Route
• Drug Class
• ATC Codes

Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
4
Orphan Drugs for Cancer Pipeline Analysis

• Orphan Designated Drugs for Cancer Treatment by
  Clinical Development Phase
• Preclinical 11
• Phase-I 25
• Phase-I/II 33
• Phase-II 68
• Phase-II/III 6
• Phase-III 41
• Table of Contents
• 1. Orphan Drug for Cancer Market Overview
• 2. Clinical Phase for Orphan Designated Cancer
  Drug Preclinical2.1 Overview2.2 Drug Profiles
  in Clinical Phase
• 3. Clinical Phase for Orphan Designated Cancer
  Drug Phase-I3.1 Overview3.2 Drug Profiles in
  Clinical Phase
• 4.Clinical Phase for Orphan Designated Cancer
  Drug Phase-I/II4.1 Overview4.2 Drug Profiles
  in Clinical Phase
• Complete report is available _at_ http//www.reportsn
  reports.com/reports/269589-orphan-drugs-for-cancer
  -pipeline-analysis.html .

Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
5
Orphan Drugs for Cancer Pipeline Analysis

• 5. Clinical Phase for Orphan Designated Cancer
  Drug Phase-II5.1 Overview5.2 Drug Profiles in
  Clinical Phase
• 6. Clinical Phase for Orphan Designated Cancer
  Drug Phase-II/III6.1 Overview6.2 Drug Profiles
  in Clinical Phase
• 7. Clinical Phase for Orphan Designated Cancer
  Drug Phase-III7.1 Overview7.2 Drug Profiles in
  Clinical Phase
• 8. Clinical Phase for Orphan Designated Cancer
  Drug Preregistration8.1 Overview8.2 Drug
  Profiles in Clinical Phase
• Buy a copy of report _at_ http//www.reportsnreports.
  com/Purchase.aspx?name269589 .
• 9. Clinical Phase for Orphan Designated Cancer
  Drug Registered9.1 Overview9.2 Drug Profiles
  in Clinical Phase
• 10. Orphan Designated Cancer Drug Available in
  Market10.1 Overview10.2Marketed Drug Profiles

Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
6
Orphan Drugs for Cancer Pipeline Analysis

• List of Tables Figures
• Each Drug Profile has Tables Representing
  Following Information
• Alternate Names
• Originator Owner
• Collaborator
• Technology Provider
• Licensee
• Highest Development Phase
• Indications
• Class
• Mechanism of Action
• ATC Code
• Designated Brand Name Orphan Designation
• Contact sales_at_reportsandreports.com / Call 1 888
  391 5441 for further information on Orphan Drugs
  for Cancer Pipeline Analysis report OR for any
  other market research and intelligence needs you
  may have for your business.

Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
7
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.